Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea: Publication Of Peer-Reviewed Study On Cellvizio

Feb 9 (Reuters) - MAUNA KEA TECHNOLOGIES SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES: CELLVIZIO COMBINED WITH ARTIFICIAL
INTELLIGENCE OUTPERFORMS STANDARD OF CARE FOR PANCREATIC CYST
DIAGNOSIS AND RISK STRATIFICATION
    * NEW PEER-REVIEWED SYSTEMATIC META-ANALYSIS PUTS CELLVIZIO
DIAGNOSTIC ACCURACY AT 99%
    * FURTHER PEER-REVIEWED CLINICAL EVIDENCE DEMONSTRATES
CELLVIZIO
ENHANCES DIAGNOSTIC ACCURACY AND PATIENT MANAGEMENT INCLUDING
SURGICAL DECISIONS

Source text for Eikon:  ID:nBw4hpk8ca 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Mauna Kea Technologies SA

See all news